

Author: Jia Li-Jing
Publisher: Springer Publishing Company
ISSN: 1590-1874
Source: Neurological Sciences, Vol.32, Iss.4, 2011-08, pp. : 609-613
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Cognitive disorders after epilepsy can have a great impact on the quality of life of epileptic patients, though it has not drawn much attention. Even after identified, it is often undertreated or has gone untreated. Memantine has been approved to treat moderate to severe Alzheimer disease (AD), which is characterized by cognitive impairment. In present study, we determined the effects of memantine on PTZ-kindled rats, which can mimic the postseizure dysfunction that resembles symptoms observed in human epilepsy. We found that memantine can ameliorate the spatial learning and memory of epileptic rats. But contrary to previous claims that memantine can improve cognition in AD patients, without serious side effects on normal learning and memory abilities, we found that rats treated only with memantine exhibited the impaired spatial learning and memory ability. We conclude that memantine can improve cognition related to an excitotoxicity-induced pathologic state, but the potential side effects of memantine on the physiological processes should be considered.
Related content


By Asle-Rousta Masoumeh Kolahdooz Zeynab Oryan Shahrbanoo Ahmadiani Abolhassan Dargahi Leila
Journal of Molecular Neuroscience, Vol. 50, Iss. 3, 2013-07 ,pp. :




By Puurunen K. Jolkkonen J. Sirvio J. Haapalinna A. Sivenius J.
Experimental Neurology, Vol. 167, Iss. 2, 2001-02 ,pp. :


By Liu Weiran Xu Jie Wang Hui Xu Chengshi Ji Chao Wang Yun Feng Chunsheng Zhang Xuena Xu Zhipeng Wu Anshi Xie Zhongcong Yue Yun
Neurological Research, Vol. 34, Iss. 1, 2012-01 ,pp. :